STAT+: Pharmalittle: We’re reading about a biotech IPO slump, FDA oversight of pharma ads, and more
Image Credit: STAT News

STAT+: Pharmalittle: We’re reading about a biotech IPO slump, FDA oversight of pharma ads, and more

Watchdoq May 28, 2025
U.S. senator wants to know how the FDA will enforce drug ad regulations after letting go numerous workers from the office that oversees them

Read Full Article